Clinical

Dataset Information

0

A PHASE 2, MULTICENTER, OPEN-LABEL STUDY OF DS-8201A IN SUBJECTS WITH HER2-EXPRESSING ADVANCED COLORECTAL CANCER[DESTINY-CRC01]


ABSTRACT: Primary objectives: To determine the objective response rate (ORR) of DS-8201a in HER2 - positive advanced metastatic colorectal cancer patients. (Cohort A). Primary endpoints: Objective response rate (ORR) per imaging assessment - Percentage of participants with objective response per independent central imaging facility review based on Response Evaluation Criteria In Solid Tumors (RECIST) version 1.1

DISEASE(S): Colorectal Cancer Nos,Human Epidermal Growth Factor Receptor 2 (her2)- Expressing Advanced Colorectal Cancer

PROVIDER: 2553617 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR

Similar Datasets

| 2262173 | ecrin-mdr-crc
| 2658293 | ecrin-mdr-crc
| 102108 | ecrin-mdr-crc
2010-08-01 | GSE16677 | GEO
2010-06-16 | E-GEOD-22110 | biostudies-arrayexpress
| PRJNA721696 | ENA
| 2363533 | ecrin-mdr-crc
2010-08-01 | E-GEOD-16677 | biostudies-arrayexpress
2010-06-05 | GSE22110 | GEO
2015-02-21 | GSE64840 | GEO